Skip to main content
. 2017 Nov 27;8(65):109301–109318. doi: 10.18632/oncotarget.22673

Table 2. The primary antibodies used in the experiment.

Primary antibody Company Dilution
Mouse monoclonal IgG to Ascl2 Millipore(MAB4418) WB: 1:500
Rabbit polyclonal IgG to CD133 Proteintech(18470-1-AP) WB: 1:500
Rabbit polyclonal IgG to CD44 Proteintech(15675-1-AP) WB: 1:200
Rabbit polyclonal IgG to Bmi1 Proteintech (10832-1-AP) WB: 1:500
Rabbit polyclonal IgG to C-myc Proteintech(10828-1-AP) WB: 1:500
Rabbit polyclonal IgG to Oct4 Proteintech(11263-1-AP) WB: 1:500
Rabbit polyclonal IgG to KLF5 Proteintech(21017-1-AP) WB: 1:500
Rabbit polyclonal IgG to KLF5 Santa Cruz Biotechnology(sc-22797) IP: 1:50;
ChIP
Rabbit polyclonal IgG to YAP1 Proteintech(13584-1-AP) WB: 1:500
Rabbit monoclonal IgG to YAP1 Cell Signaling(#14074) IP: 1:50;
ChIP
Rabbit polyclonal IgG to MST1 Cell Signaling(#3682) WB: 1:1000
Rabbit monoclonal IgG to Phospho-YAP(Ser127) Cell Signaling(#13008) WB: 1:1000
Mouse monoclonal IgG to β-actin Proteintech(66009-1-Ig) WB: 1:4000
Rabbit polyclonal IgG to Lamin B1 Proteintech(12987-1-AP) WB: 1:5000